ZEALAND PHARMA AS DKK1ZEALAND PHARMA AS DKK1ZEALAND PHARMA AS DKK1

ZEALAND PHARMA AS DKK1

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−4.19DKK
Revenue estimate
‪9.12 M‬DKK
Market capitalization
‪39.39 B‬DKK
−12.5DKK
‪−703.74 M‬DKK
‪342.79 M‬DKK
‪55.57 M‬
Beta (1Y)
1.09

About ZEALAND PHARMA A/S

CEO
Adam Sinding Steensberg
Headquarters
Soborg
Employees (FY)
253
Founded
1997
ISIN
DK0060257814
FIGI
BBG00JVX9822
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0NZU is 618.5 DKK — it has decreased by 1.55% in the past 24 hours. Watch ZEALAND PHARMA AS DKK1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange ZEALAND PHARMA AS DKK1 stocks are traded under the ticker 0NZU.
ZEALAND PHARMA AS DKK1 is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
0NZU stock is 6.06% volatile and has beta coefficient of 1.09. Track ZEALAND PHARMA AS DKK1 stock price on the chart and check out the list of the most volatile stocks — is ZEALAND PHARMA AS DKK1 there?
0NZU earnings for the last quarter are 1.27 DKK per share, whereas the estimation was −2.33 DKK resulting in a 154.62% surprise. The estimated earnings for the next quarter are −3.87 DKK per share. See more details about ZEALAND PHARMA AS DKK1 earnings.
ZEALAND PHARMA AS DKK1 revenue for the last quarter amounts to ‪295.52 M‬ DKK despite the estimated figure of ‪57.93 M‬ DKK. In the next quarter revenue is expected to reach ‪10.16 M‬ DKK.
Yes, you can track ZEALAND PHARMA AS DKK1 financials in yearly and quarterly reports right on TradingView.
0NZU stock has fallen by 1.00% compared to the previous week, the month change is a 9.55% fall, over the last year ZEALAND PHARMA AS DKK1 has showed a 166.72% increase.
0NZU net income for the last quarter is ‪−264.75 M‬ DKK, while the quarter before that showed ‪74.15 M‬ DKK of net income which accounts for −457.07% change. Track more ZEALAND PHARMA AS DKK1 financial stats to get the full picture.
Today ZEALAND PHARMA AS DKK1 has the market capitalization of ‪39.23 B‬, it has decreased by 3.88% over the last week.
No, 0NZU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0NZU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZEALAND PHARMA AS DKK1 stock right from TradingView charts — choose your broker and connect to your account.
0NZU reached its all-time high on Mar 7, 2024 with the price of 749.0 DKK, and its all-time low was 47.0 DKK and was reached on Nov 2, 2011. View more price dynamics on 0NZU chart.
See other stocks reaching their highest and lowest prices.
As of May 3, 2024, the company has 253.00 employees. See our rating of the largest employees — is ZEALAND PHARMA AS DKK1 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZEALAND PHARMA AS DKK1 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZEALAND PHARMA AS DKK1 stock shows the buy signal. See more of ZEALAND PHARMA AS DKK1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ZEALAND PHARMA AS DKK1 future price: according to them, 0NZU price has a max estimate of 840.00 DKK and a min estimate of 600.00 DKK. Watch 0NZU chart and read a more detailed ZEALAND PHARMA AS DKK1 stock forecast: see what analysts think of ZEALAND PHARMA AS DKK1 and suggest that you do with its stocks.